Dr. Appelbaum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-1000Fax+1 415-502-1976
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2019
- University of California (San Francisco)Residency, Internal Medicine, 2013 - 2016
- Yale School of MedicineClass of 2013
Certifications & Licensure
- CA State Medical License 2015 - Present
- ID State Medical License 2022 - 2025
- WA State Medical License 2016 - 2025
- AK State Medical License 2022 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 31 citationsFatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report.Jacob S. Appelbaum, David Wells, Joseph B. Hiatt, Gideon Steinbach, F. Marc Stewart
Journal for Immunotherapy of Cancer. 2018-08-31 - 2 citationsPhase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and O...Colin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, Anna B Halpern, Jacob S Appelbaum
Cancers. 2022-06-14 - 1 citationsPhase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival
Blood Advances. 2023-09-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: